Biogen vet’s new startup raises nine-figure round

A biotech startup led by former Biogen Inc. and Amgen Inc. executive Jo Viney is pushing into autoimmune diseases with the help of $121 million in new funds.

Seismic Therapeutic Inc., which emerged from stealth in February 2022, announced its Series B on Monday. It's easily one of the largest venture capital raises of the year amid a tough market for young biotechs.

Bessemer Venture Partners led the round. The venture arm of Amgen, where Viney once led inflammation research, joined in, as did Codon…

Previous Hospital inclusion leader says to tackle health disparities, heal caregivers first
Next 5 Things: New affordable project proposed in R Street Corridor, office building could be converted